インターフェロンの世界市場 2024-2028

インターフェロン市場は2023-2028年に26億5,000万米ドル、予測期間中のCAGRは4.65％で成長すると予測されます。

当レポートでは、インターフェロン市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、ウイルス感染症の増加、自己免疫疾患の症例の増加、組換え型インターフェロンの開発におけるバイオテクノロジーの進歩によって牽引されています。

本調査では、今後数年間のインターフェロン市場の成長を牽引する主な要因の一つとして、インターフェロンと他の薬剤クラス別を含む併用療法の探求を挙げています。また、個別化医療が重視されるようになり、バイオシミラーに対する需要が増加していることも、市場の大きな需要につながると思われます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• インターフェロンの世界市場 2018-2022
• タイプセグメント分析 2018-2022
• 適応症セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• ベータ：市場規模と予測 2023-2028
• アルファ：市場規模と予測 2023-2028
• ガンマ：市場規模と予測 2023-2028
• 市場機会：タイプ別

第7章 市場セグメンテーション適応症別

• 市場セグメント
• 比較適応症別
• 多発性硬化症：市場規模と予測 2023-2028
• C型肝炎：市場規模と予測 2023-2028
• 黒色腫：市場規模と予測 2023-2028
• 白血病：市場規模と予測 2023-2028
• その他の適応症：市場規模と予測 2023-2028
• 市場機会適応症別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• 3SBio Inc.
• Bayer AG
• Biogen Inc.
• Biosidus SA
• Bristol Myers Squibb Co.
• F. Hoffmann La Roche Ltd.
• Mega Labs SA
• Merck KGaA
• NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC
• Novartis AG
• Pfizer Inc.
• PharmaEssentia Corp.
• Sanfer
• Synairgen plc
• Zydus Lifesciences Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global interferons market 2018 - 2022 ($ billion)
• Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• Exhibits20: Historic Market Size - Indication Segment 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Interferon beta - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Data Table on Interferon beta - Market size and forecast 2023-2028 ($ billion)
• Exhibits36: Chart on Interferon beta - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Interferon beta - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Interferon alfa - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Data Table on Interferon alfa - Market size and forecast 2023-2028 ($ billion)
• Exhibits40: Chart on Interferon alfa - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Interferon alfa - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Interferon gamma - Market size and forecast 2023-2028 ($ billion)
• Exhibits43: Data Table on Interferon gamma - Market size and forecast 2023-2028 ($ billion)
• Exhibits44: Chart on Interferon gamma - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Interferon gamma - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by Type ($ billion)
• Exhibits47: Data Table on Market opportunity by Type ($ billion)
• Exhibits48: Chart on Indication - Market share 2023-2028 (%)
• Exhibits49: Data Table on Indication - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by Indication
• Exhibits51: Data Table on Comparison by Indication
• Exhibits52: Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ billion)
• Exhibits53: Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ billion)
• Exhibits54: Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Hepatitis C - Market size and forecast 2023-2028 ($ billion)
• Exhibits57: Data Table on Hepatitis C - Market size and forecast 2023-2028 ($ billion)
• Exhibits58: Chart on Hepatitis C - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Hepatitis C - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Melanoma - Market size and forecast 2023-2028 ($ billion)
• Exhibits61: Data Table on Melanoma - Market size and forecast 2023-2028 ($ billion)
• Exhibits62: Chart on Melanoma - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Melanoma - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on Leukemia - Market size and forecast 2023-2028 ($ billion)
• Exhibits65: Data Table on Leukemia - Market size and forecast 2023-2028 ($ billion)
• Exhibits66: Chart on Leukemia - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on Leukemia - Year-over-year growth 2023-2028 (%)
• Exhibits68: Chart on Other indications - Market size and forecast 2023-2028 ($ billion)
• Exhibits69: Data Table on Other indications - Market size and forecast 2023-2028 ($ billion)
• Exhibits70: Chart on Other indications - Year-over-year growth 2023-2028 (%)
• Exhibits71: Data Table on Other indications - Year-over-year growth 2023-2028 (%)
• Exhibits72: Market opportunity by Indication ($ billion)
• Exhibits73: Data Table on Market opportunity by Indication ($ billion)
• Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits77: Chart on Geographic comparison
• Exhibits78: Data Table on Geographic comparison
• Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits108: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits109: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits111: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibits112: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibits113: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits115: Market opportunity By Geographical Landscape ($ billion)
• Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits117: Impact of drivers and challenges in 2023 and 2028
• Exhibits118: Overview on Criticality of inputs and Factors of differentiation
• Exhibits119: Overview on factors of disruption
• Exhibits120: Impact of key risks on business
• Exhibits121: Vendors covered
• Exhibits122: Matrix on vendor position and classification
• Exhibits123: 3SBio Inc. - Overview
• Exhibits124: 3SBio Inc. - Product / Service
• Exhibits125: 3SBio Inc. - Key offerings
• Exhibits126: Bayer AG - Overview
• Exhibits127: Bayer AG - Business segments
• Exhibits128: Bayer AG - Key news
• Exhibits129: Bayer AG - Key offerings
• Exhibits130: Bayer AG - Segment focus
• Exhibits131: Biogen Inc. - Overview
• Exhibits132: Biogen Inc. - Product / Service
• Exhibits133: Biogen Inc. - Key news
• Exhibits134: Biogen Inc. - Key offerings
• Exhibits135: Biosidus SA - Overview
• Exhibits136: Biosidus SA - Product / Service
• Exhibits137: Biosidus SA - Key offerings
• Exhibits138: Bristol Myers Squibb Co. - Overview
• Exhibits139: Bristol Myers Squibb Co. - Product / Service
• Exhibits140: Bristol Myers Squibb Co. - Key news
• Exhibits141: Bristol Myers Squibb Co. - Key offerings
• Exhibits142: F. Hoffmann La Roche Ltd. - Overview
• Exhibits143: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits144: F. Hoffmann La Roche Ltd. - Key news
• Exhibits145: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits146: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits147: Mega Labs SA - Overview
• Exhibits148: Mega Labs SA - Product / Service
• Exhibits149: Mega Labs SA - Key offerings
• Exhibits150: Merck KGaA - Overview
• Exhibits151: Merck KGaA - Business segments
• Exhibits152: Merck KGaA - Key news
• Exhibits153: Merck KGaA - Key offerings
• Exhibits154: Merck KGaA - Segment focus
• Exhibits155: NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC - Overview
• Exhibits156: NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC - Product / Service
• Exhibits157: NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC - Key offerings
• Exhibits158: Novartis AG - Overview
• Exhibits159: Novartis AG - Business segments
• Exhibits160: Novartis AG - Key news
• Exhibits161: Novartis AG - Key offerings
• Exhibits162: Novartis AG - Segment focus
• Exhibits163: Pfizer Inc. - Overview
• Exhibits164: Pfizer Inc. - Product / Service
• Exhibits165: Pfizer Inc. - Key news
• Exhibits166: Pfizer Inc. - Key offerings
• Exhibits167: PharmaEssentia Corp. - Overview
• Exhibits168: PharmaEssentia Corp. - Product / Service
• Exhibits169: PharmaEssentia Corp. - Key offerings
• Exhibits170: Sanfer - Overview
• Exhibits171: Sanfer - Product / Service
• Exhibits172: Sanfer - Key offerings
• Exhibits173: Synairgen plc - Overview
• Exhibits174: Synairgen plc - Product / Service
• Exhibits175: Synairgen plc - Key offerings
• Exhibits176: Zydus Lifesciences Ltd. - Overview
• Exhibits177: Zydus Lifesciences Ltd. - Business segments
• Exhibits178: Zydus Lifesciences Ltd. - Key offerings
• Exhibits179: Zydus Lifesciences Ltd. - Segment focus
• Exhibits180: Inclusions checklist
• Exhibits181: Exclusions checklist
• Exhibits182: Currency conversion rates for US$
• Exhibits183: Research methodology
• Exhibits184: Validation techniques employed for market sizing
• Exhibits185: Information sources
• Exhibits186: List of abbreviations

The interferons market is forecasted to grow by USD 2.65 bn during 2023-2028, accelerating at a CAGR of 4.65% during the forecast period. The report on the interferons market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of viral infections, rising cases of autoimmune diseases, and advancements in biotechnology in developing recombinant interferons.

Technavio's interferons market is segmented as below:

By Type

• Interferon beta
• Interferon alfa
• Interferon gamma

By Indication

• Multiple sclerosis
• Hepatitis C
• Melanoma
• Leukemia
• Other indications

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the exploration of combination therapies involving interferons and other classes of drugs as one of the prime reasons driving the interferons market growth during the next few years. Also, growing emphasis on personalized medicine and increasing demand for biosimilars will lead to sizable demand in the market.

The report on the interferons market covers the following areas:

• Interferons market sizing
• Interferons market forecast
• Interferons market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading interferons market vendors that include 3SBio Inc., Bayer AG, Biogen Inc., Biosidus SA, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Mega Labs SA, Merck KGaA, NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC, Novartis AG, Pfizer Inc., PharmaEssentia Corp., Sanfer, Synairgen plc, and Zydus Lifesciences Ltd.. Also, the interferons market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global interferons market 2018 - 2022
• 4.2 Type Segment Analysis 2018 - 2022
• 4.3 Indication Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Type

• 6.1 Market segments
• 6.2 Comparison by Type
• 6.3 Interferon beta - Market size and forecast 2023-2028
• 6.4 Interferon alfa - Market size and forecast 2023-2028
• 6.5 Interferon gamma - Market size and forecast 2023-2028
• 6.6 Market opportunity by Type

7 Market Segmentation by Indication

• 7.1 Market segments
• 7.2 Comparison by Indication
• 7.3 Multiple sclerosis - Market size and forecast 2023-2028
• 7.4 Hepatitis C - Market size and forecast 2023-2028
• 7.5 Melanoma - Market size and forecast 2023-2028
• 7.6 Leukemia - Market size and forecast 2023-2028
• 7.7 Other indications - Market size and forecast 2023-2028
• 7.8 Market opportunity by Indication

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 UK - Market size and forecast 2023-2028
• 9.9 China - Market size and forecast 2023-2028
• 9.10 Germany - Market size and forecast 2023-2028
• 9.11 Japan - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 3SBio Inc.
• 12.4 Bayer AG
• 12.5 Biogen Inc.
• 12.6 Biosidus SA
• 12.7 Bristol Myers Squibb Co.
• 12.8 F. Hoffmann La Roche Ltd.
• 12.9 Mega Labs SA
• 12.10 Merck KGaA
• 12.11 NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC
• 12.12 Novartis AG
• 12.13 Pfizer Inc.
• 12.14 PharmaEssentia Corp.
• 12.15 Sanfer
• 12.16 Synairgen plc
• 12.17 Zydus Lifesciences Ltd.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations